Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122193) titled 'A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Merz North America, Inc.
Condition:
Neuromuscular Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
incobotulinumtoxinA
Botulinum Toxins, Type A...